Related Experiment Videos
Prostaglandin E2 (PGE2) vaginal gel for cervical ripening
M S Chatterjee1, K Ramchandran, J Ferlita
1Department of Obstetrics and Gynecology, University of New Mexico, School of Medicine, Albuquerque 87131.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|February 25, 1991
Summary
A 2 mg dose of prostaglandin E2 (PGE2) administered intravaginally safely ripens the cervix. This method improved cervical ripening compared to placebo, without adverse effects, making it a viable option for labor induction.
Area of Science:
- Obstetrics and Gynecology
- Reproductive Medicine
- Pharmacology
Background:
- Cervical ripening is crucial for successful labor induction.
- Prostaglandin E2 (PGE2) is used for cervical ripening via various routes.
- Optimal PGE2 dosage requires investigation to balance efficacy and safety.
Purpose of the Study:
- To evaluate the efficacy and safety of a 2 mg intravaginal dose of prostaglandin E2 (PGE2) for cervical ripening.
- To compare the effects of 2 mg PGE2 with placebo in a randomized, double-blinded study.
Main Methods:
- A randomized, double-blinded study design was employed.
- 2 mg of PGE2 in a hydroxyethyl cellulose gel medium was administered intravaginally.
- The Bishop score was used to assess cervical ripening.
- Patients receiving PGE2 were compared to a placebo group.
Main Results:
- A significant increase in the Bishop score (40% higher) was observed in the PGE2 group compared to placebo.
- No adverse side effects, such as uterine hypertonus or fetal heart rate changes, were reported.
- The 2 mg dose demonstrated efficacy without the adverse events associated with higher doses.
Conclusions:
- Intravaginal administration of 2 mg PGE2 is a safe and effective method for cervical ripening prior to labor induction.
- This dosage offers a favorable balance of efficacy and safety, avoiding side effects seen with higher doses.
- The study supports the use of 2 mg PGE2 as a valuable tool in obstetric practice for labor induction.